Abbott Laboratories (BMV:ABT)

Market Cap	3.71T
Revenue (ttm)	804.18B
Net Income (ttm)	255.43B
Shares Out	n/a
EPS (ttm)	146.02
PE Ratio	14.51
Forward PE	21.67
Dividend	45.08 (2.00%)
Ex-Dividend Date	Jan 15, 2026

Volume	240
Average Volume	681
Open	2,254.00
Previous Close	2,310.00
Day's Range	2,254.00 - 2,254.00
52-Week Range	2,194.99 - 2,915.60
Beta	0.72
RSI	41.06
Earnings Date	Jan 22, 2026

About Abbott Laboratories

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism,...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1888
• Employees: 114,000
• Stock Exchange: Mexican Stock Exchange
• Ticker Symbol: ABT

Financial Performance

In 2024, Abbott Laboratories's revenue was $41.95 billion, an increase of 4.59% compared to the previous year's $40.11 billion. Earnings were $13.35 billion, an increase of 134.19%.

Financial numbers in USD